A Season of Reflection and Progress in Wound Management
Summary: December 2025 editorial by John C. Lantis, II, MD, FACS uses the holiday season as a metaphor for reflection, celebration, and new beginnings amid uncertainties in wound care. Highlights progress: increasing stability in tissue/biologic products, shift to online-only journal format, surge in international submissions offering global insights, upcoming consensus documents on debridement across sites and postoperative dehiscence management. Anticipates 18 months of studies on tissue products in DFUs/VLUs, long-term pressure injury outcomes, and atypical wounds. Encourages recharging, engaging with content for better patient understanding (medical/psychological/social), and advancing knowledge to improve lives. Welcomes feedback to enhance article value.
Key Highlights:
- Progress: Biologics stability, international research growth, Wound Care Collaborative Community contributions (image quality, trial designs, PROs).
- Upcoming: Consensus on debridement/dehiscence; studies on healing trajectories, epidemiology.
- Message: Reflect on commitment; reduce suffering, heal wounds, elevate QoL.
- Relevance: Year-end overview tying to synthetic/innovative therapies and global chronic wound challenges.
Keywords: wound management progress, biologic products, debridement consensus, atypical wounds